Literature DB >> 25571972

Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death.

S Vogel1, V Börger1, C Peters1, M Förster1, P Liebfried2, K Metzger3, R Meisel4, W Däubener2, T Trapp1, J C Fischer1, M Gawaz3, R V Sorg1.   

Abstract

Tissue damage due to apoptotic or necrotic cell death typically initiates distinct cellular responses, leading either directly to tissue repair and regeneration or to immunological processes first, to clear the site, for example, of potentially damage-inducing agents. Mesenchymal stem cells (MSC) as well as immature dendritic cells (iDC) and monocytes migrate to injured tissues. MSC have regenerative capacity, whereas monocytes and iDC have a critical role in inflammation and induction of immune responses, including autoimmunity after tissue damage. Here, we investigated the influence of apoptotic and necrotic cell death on recruitment of MSC, monocytes and iDC, and identified hepatocyte growth factor (HGF) and the alarmin high mobility group box 1 (HMGB1) as key factors differentially regulating these migratory responses. MSC, but not monocytes or iDC, were attracted by apoptotic cardiomyocytic and neuronal cells, whereas necrosis induced migration of monocytes and iDC, but not of MSC. Only apoptotic cell death resulted in HGF production and HGF-mediated migration of MSC towards the apoptotic targets. In contrast, HMGB1 was predominantly released by the necrotic cells and mediated recruitment of monocytes and iDC via the receptor of advanced glycation end products. Moreover, necrotic cardiomyocytic and neuronal cells caused an HMGB1/toll-like receptor-4-dependent inhibition of MSC migration towards apoptosis or HGF, while recruitment of monocytes and iDC by necrosis or HMGB1 was not affected by apoptotic cells or HGF. Thus, the type of cell death differentially regulates recruitment of either MSC or monocytes and iDC through HGF and HMGB1, respectively, with a dominant, HMGB1-mediated role of necrosis in determining tropism after tissue injury.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25571972      PMCID: PMC4572869          DOI: 10.1038/cdd.2014.225

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  60 in total

1.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 2.  Mesenchymal stem cells in health and disease.

Authors:  Antonio Uccelli; Lorenzo Moretta; Vito Pistoia
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

3.  Cellular immunity of patients with malignant glioma: prerequisites for dendritic cell vaccination immunotherapy.

Authors:  Marion Rapp; Zakir Ozcan; Hans-Jakob Steiger; Peter Wernet; Michael C Sabel; Rüdiger V Sorg
Journal:  J Neurosurg       Date:  2006-07       Impact factor: 5.115

4.  High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin.

Authors:  De Yang; Qian Chen; Huan Yang; Kevin J Tracey; Michael Bustin; Joost J Oppenheim
Journal:  J Leukoc Biol       Date:  2006-09-11       Impact factor: 4.962

5.  The extracellular release of HMGB1 during apoptotic cell death.

Authors:  Charles W Bell; Weiwen Jiang; Charles F Reich; David S Pisetsky
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-19       Impact factor: 4.249

6.  Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.

Authors:  Christiane A Opitz; Ulrike M Litzenburger; Christian Lutz; Tobias V Lanz; Isabel Tritschler; Alexandra Köppel; Eva Tolosa; Maik Hoberg; Jan Anderl; Wilhelm K Aicher; Michael Weller; Wolfgang Wick; Michael Platten
Journal:  Stem Cells       Date:  2009-04       Impact factor: 6.277

7.  Over-expression of hepatocyte growth factor in smooth muscle cells regulates endothelial progenitor cells differentiation, migration and proliferation.

Authors:  Guangxu Zhu; Lan Huang; Mingbao Song; Zhengping Yu; Xiaojing Wu; Xiaohui Zhao; Jun Jin; Gang Zhao; Jianfei Chen; Siyong Yu
Journal:  Int J Cardiol       Date:  2008-12-17       Impact factor: 4.164

8.  Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells.

Authors:  Lara Campana; Lidia Bosurgi; Marco E Bianchi; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  J Leukoc Biol       Date:  2009-05-04       Impact factor: 4.962

9.  HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4.

Authors:  Milena Schiraldi; Angela Raucci; Laura Martínez Muñoz; Elsa Livoti; Barbara Celona; Emilie Venereau; Tiziana Apuzzo; Francesco De Marchis; Mattia Pedotti; Angela Bachi; Marcus Thelen; Luca Varani; Mario Mellado; Amanda Proudfoot; Marco Emilio Bianchi; Mariagrazia Uguccioni
Journal:  J Exp Med       Date:  2012-02-27       Impact factor: 14.307

Review 10.  Mesenchymal stem cells and cardiac repair.

Authors:  Catharina Nesselmann; Nan Ma; Karen Bieback; Wolfgang Wagner; Anthony Ho; Yrjö T Konttinen; Hao Zhang; Mihail E Hinescu; Gustav Steinhoff
Journal:  J Cell Mol Med       Date:  2008-08-05       Impact factor: 5.310

View more
  18 in total

1.  Critical role of RAGE and HMGB1 in inflammatory heart disease.

Authors:  Anna Bangert; Martin Andrassy; Anna-Maria Müller; Mariella Bockstahler; Andrea Fischer; Christian H Volz; Christoph Leib; Stefan Göser; Sevil Korkmaz-Icöz; Stefan Zittrich; Andreas Jungmann; Felix Lasitschka; Gabriele Pfitzer; Oliver J Müller; Hugo A Katus; Ziya Kaya
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-29       Impact factor: 11.205

2.  Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes.

Authors:  Sebastian Vogel; Dominik Rath; Oliver Borst; Andreas Mack; Patricia Loughran; Michael T Lotze; Matthew D Neal; Timothy R Billiar; Meinrad Gawaz
Journal:  Biochem Biophys Res Commun       Date:  2016-07-20       Impact factor: 3.575

3.  Improved Mobilization of Exogenous Mesenchymal Stem Cells to Bone for Fracture Healing and Sex Difference.

Authors:  Wei Yao; Yu-An Evan Lay; Alexander Kot; Ruiwu Liu; Hongliang Zhang; Haiyan Chen; Kit Lam; Nancy E Lane
Journal:  Stem Cells       Date:  2016-07-15       Impact factor: 6.277

4.  Platelets at the crossroads of thrombosis, inflammation and haemolysis.

Authors:  Sebastian Vogel; Swee Lay Thein
Journal:  Br J Haematol       Date:  2018-01-30       Impact factor: 6.998

5.  The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinase.

Authors:  Sebastian Vogel; Taruna Arora; Xunde Wang; Laurel Mendelsohn; James Nichols; Darlene Allen; Arun S Shet; Christian A Combs; Zenaide M N Quezado; Swee Lay Thein
Journal:  Blood Adv       Date:  2018-10-23

6.  Platelet-derived HMGB1 is a critical mediator of thrombosis.

Authors:  Sebastian Vogel; Rebecca Bodenstein; Qiwei Chen; Susanne Feil; Robert Feil; Johannes Rheinlaender; Tilman E Schäffer; Erwin Bohn; Julia-Stefanie Frick; Oliver Borst; Patrick Münzer; Britta Walker; Justin Markel; Gabor Csanyi; Patrick J Pagano; Patricia Loughran; Morgan E Jessup; Simon C Watkins; Grant C Bullock; Jason L Sperry; Brian S Zuckerbraun; Timothy R Billiar; Michael T Lotze; Meinrad Gawaz; Matthew D Neal
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

7.  Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis.

Authors:  Min-Jung Park; Seung Hoon Lee; Su-Jin Moon; Jung-Ah Lee; Eun-Jung Lee; Eun-Kyung Kim; Jin-Sil Park; Jennifer Lee; Jun-Ki Min; Seok Jung Kim; Sung-Hwan Park; Mi-La Cho
Journal:  Sci Rep       Date:  2016-11-02       Impact factor: 4.379

8.  A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients.

Authors:  Herbert J Zeh; Nathan Bahary; Brian A Boone; Aatur D Singhi; Jennifer Lee Miller-Ocuin; Daniel P Normolle; Amer H Zureikat; Melissa E Hogg; David L Bartlett; Kenneth K Lee; Allan Tsung; J Wallis Marsh; Pranav Murthy; Daolin Tang; Natalie Seiser; Ravi K Amaravadi; Virginia Espina; Lance Liotta; Michael T Lotze
Journal:  Clin Cancer Res       Date:  2020-03-10       Impact factor: 12.531

Review 9.  DAMPs from Cell Death to New Life.

Authors:  Emilie Vénéreau; Chiara Ceriotti; Marco Emilio Bianchi
Journal:  Front Immunol       Date:  2015-08-18       Impact factor: 7.561

Review 10.  Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies.

Authors:  Heidi R Hofer; Rocky S Tuan
Journal:  Stem Cell Res Ther       Date:  2016-09-09       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.